Literature DB >> 23151496

Putting risk compensation to rest: reframing the relationship between risk behavior and antiretroviral therapy among injection drug users.

Brandon D L Marshall, Evan Wood.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23151496      PMCID： PMC3954705          DOI： 10.1097/QAD.0b013e3283519b42

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  13 in total

Review 1.  Risk compensation: the Achilles' heel of innovations in HIV prevention?

Authors:  Michael M Cassell; Daniel T Halperin; James D Shelton; David Stanton
Journal:  BMJ       Date:  2006-03-11

2.  Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.

Authors:  Amy R Knowlton; Julia H Arnsten; Lois J Eldred; James D Wilkinson; Starley B Shade; Amy S Bohnert; Cui Yang; Lawrence S Wissow; David W Purcell
Journal:  AIDS Patient Care STDS       Date:  2010-07       Impact factor: 5.078

3.  Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users.

Authors:  D Vlahov; M Safaien; S Lai; S A Strathdee; L Johnson; T Sterling; D D Celentano
Journal:  AIDS       Date:  2001-11-23       Impact factor: 4.177

4.  Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users.

Authors:  A-D Bouhnik; J P Moatti; D Vlahov; H Gallais; P Dellamonica; Y Obadia
Journal:  J Epidemiol Community Health       Date:  2002-05       Impact factor: 3.710

5.  Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users.

Authors:  Amy Knowlton; Julia Arnsten; Lois Eldred; James Wilkinson; Marc Gourevitch; Starley Shade; Krista Dowling; David Purcell
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

6.  Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review.

Authors:  Nicole Crepaz; Trevor A Hart; Gary Marks
Journal:  JAMA       Date:  2004-07-14       Impact factor: 56.272

7.  Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.

Authors:  Tsung-chieh Fu; Ryan P Westergaard; Bryan Lau; David D Celentano; David Vlahov; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

8.  Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users.

Authors:  Waimar Tun; David D Celentano; David Vlahov; Steffanie A Strathdee
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

9.  Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  Waimar Tun; Stephen J Gange; David Vlahov; Steffanie A Strathdee; David D Celentano
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  2 in total

1.  Modeling scenarios for the end of AIDS.

Authors:  Viviane D Lima; Harsha Thirumurthy; James G Kahn; Jorge Saavedra; Carlos F Cárceres; Alan Whiteside
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

2.  The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study.

Authors:  Anna Hayden; Kanna Hayashi; Huiru Dong; Michael-John Milloy; Thomas Kerr; Julio S G Montaner; Evan Wood
Journal:  BMC Public Health       Date:  2014-11-06       Impact factor: 3.295
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.